Treatment with CatL-inh protected diabetes-prone NOD mice from subsequently occurring diabetes such as high blood sugar and urine sugar while there was no therapeutic effect of cathepsin B inhibitor (CatB-inh) and cathepsin S inhibitor (CatS-inh) (Figure 1A, B). The gene discussed is TYRP1; the disease is diabetes mellitus.